Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Key facts

Sponsor

University of Iowa

Principal Investigator

Michael E Shy, MD

University of Iowa

Enrollment

1050 enrolled

Eligibility

All sexes

Timeline

2010 – 2026

Study locations (22)

• Cedars-Sinai Medical Center, Los Angeles, California, United States
• Stanford University, Palo Alto, California, United States
• University of Colorado Hospital, Aurora, Colorado, United States
• Connecticut Children's Medical Center, Hartford, Connecticut, United States
• University of Miami, Miami, Florida, United States
• University of Iowa, Iowa City, Iowa, United States
• Johns Hopkins University, Baltimore, Maryland, United States
• Harvard/Massachusetts General Hospital, Boston, Massachusetts, United States
• University of Michigan, Ann Arbor, Michigan, United States
• University of Minnesota, Maple Grove, Minnesota, United States
• University of Rochester, Rochester, New York, United States
• University of North Carolina, Chapel Hill, North Carolina, United States
• Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
• University of Pennsylvania, Philadelphia, Pennsylvania, United States
• St. Jude Children's Research Hospital, Memphis, Tennessee, United States
• +7 more locations on ClinicalTrials.gov

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS) · Muscular Dystrophy Association · University of Rochester · University of Pennsylvania · King's College Hospital NHS Trust · Sydney Children's Hospitals Network · Children's Hospital of Philadelphia · University of Miami · Johns Hopkins University · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Cedars-Sinai Medical Center · Nemours Children's Clinic · Stanford University · University of Minnesota · Massachusetts General Hospital · University of Colorado, Denver · Children's National Research Institute · University of Michigan · St. Jude Children's Research Hospital · Connecticut Children's Medical Center · Seattle Children's Hospital · The Hospital for Sick Children

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Autosomal dominant Charcot-Marie-Tooth disease type 2

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT01193075
  Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
  Michael Shy

See all trials for Autosomal dominant Charcot-Marie-Tooth disease type 2 →